Select a Sector or Industry
Free Cash Flow Rankings for Biotechnology Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Free Cash Flow
|
Pro Rating
|
|---|---|---|---|---|
| 1 | AMGN | Amgen | 828.00M | Go Pro |
| 2 | GILD | Gilead Sciences | 429.77M | Go Pro |
| 3 | CELG | Celgene Corporation | 282.40M | Go Pro |
| 4 | SHPGY | Shire | 233.70M | Go Pro |
| 5 | BIIB | Biogen Idec | 140.07M | Go Pro |
| 6 | ALXN | Alexion Pharmaceuticals | 59.04M | Go Pro |
| 7 | VPHM | ViroPharma | 53.04M | Go Pro |
| 8 | ILMN | Illumina | 52.36M | Go Pro |
| 9 | QCOR | Questcor Pharmaceuticals | 40.61M | Go Pro |
| 10 | MNTA | Momenta Pharmaceuticals | 33.49M | Go Pro |
| 11 | SPPI | Spectrum Pharmaceuticals | 26.81M | Go Pro |
| 12 | JAZZ | Jazz Pharmaceuticals | 24.01M | Go Pro |
| 13 | BDSI | BioDelivery Sciences International | 22.48M | Go Pro |
| 14 | IMMU | Immunomedics | 21.13M | Go Pro |
| 15 | PDLI | PDL BioPharma | 17.89M | Go Pro |
| 16 | SSRX | 3SBio | 16.24M | Go Pro |
| 17 | YMI | YM BioSciences | 13.44M | Go Pro |
| 18 | THLD | Threshold Pharmaceuticals | 12.27M | Go Pro |
| 19 | AGEN | Agenus | 11.27M | Go Pro |
| 20 | CRL | Charles River Laboratories International | 11.16M | Go Pro |
| 21 | CBPO | China Biologic Products | 10.64M | Go Pro |
| 22 | SVA | Sinovac Biotech | 9.76M | Go Pro |
| 23 | SNTS | Santarus | 7.11M | Go Pro |
| 24 | CDXS | Codexis | 5.41M | Go Pro |
| 25 | EBS | Emergent BioSolutions | 5.256M | Go Pro |
| 26 | IMGN | ImmunoGen | 4.971M | Go Pro |
| 27 | TTHI | Transition Therapeutics | 4.92M | Go Pro |
| 28 | NKBP | China Nuokang Bio - Pharmaceutical | 4.37M | Go Pro |
| 29 | CRIS | Curis | 4.303M | Go Pro |
| 30 | BSTC | Biospecifics Technologies | 4.10M | Go Pro |
| 31 | OMPI | Obagi Medical Products | 3.037M | Go Pro |
| 32 | SGMO | Sangamo BioSciences | 2.649M | Go Pro |
| 33 | SNT | Senesco Technologies | 2.294M | Go Pro |
| 34 | CBM | Cambrex Corporation | 2.15M | Go Pro |
| 35 | RGEN | Repligen Corporation | 1.577M | Go Pro |
| 36 | ENMD | EntreMed | 0.9468M | Go Pro |
| 37 | PIP | PharmAthene | 0.8588M | Go Pro |
| 38 | IG | IGI Laboratories | -0.06M | Go Pro |
| 39 | ACOR | Acorda Therapeutics | -0.092M | Go Pro |
| 40 | ENZN | Enzon Pharmaceuticals | -0.496M | Go Pro |
| 41 | HSKA | Heska Corporation | -0.526M | Go Pro |
| 42 | CRMD | CorMedix | -0.90M | Go Pro |
| 43 | MNOV | MediciNova | -0.946M | Go Pro |
| 44 | DARA | DARA Biosciences | -1.410M | Go Pro |
| 45 | NABI | Nabi Biopharmaceuticals | -1.515M | Go Pro |
| 46 | OPXA | Opexa Therapeutics | -1.52M | Go Pro |
| 47 | ABIO | Arca Biopharma | -1.656M | Go Pro |
| 48 | NLNK | NewLink Genetics Corporation | -1.80M | Go Pro |
| 49 | GNBT | Generex Biotechnology Corporation | -1.840M | Go Pro |
| 50 | ANIK | Anika Therapeutics | -1.914M | Go Pro |
